Abstract
We report the synthesis of DO3A derivatives of 2,2′-diaminobiphenyl (1a,b) and their Gd complexes of the type [Gd(1)(H2O)]·xH 2O (2a,b) for use as new MRI blood-pool contrast agents (BPCAs) that provide strong and prolonged vascular enhancement. Pharmacokinetic inertness of 2 compares well with that of structurally related Dotarem, a DOTA-based MRI CA currently in use. The R1 relaxivity in water reaches 7.3 mM -1 s-1, which is approximately twice as high as that of Dotarem (R1 = 3.9 mM-1 s-1). They show interaction with HSA to give association constants (Ka) in the order of two (∼102), revealing the existence of the blood-pool effect. The in vivo MR images of mice obtained with 2 are coherent, showing strong signal enhancement in both heart, abdominal aorta, and small vessels. Furthermore, the brain tumor is vividly enhanced for an extended period of time.
Original language | English |
---|---|
Pages (from-to) | 1003-1007 |
Number of pages | 5 |
Journal | ACS Medicinal Chemistry Letters |
Volume | 3 |
Issue number | 12 |
DOIs | |
State | Published - 13 Dec 2012 |
Keywords
- DO3A
- Gd chelates
- MRI BPCA
- biphenyl
- brain tumor